Blood pressure increased: FDA reporting patterns
151,165 FDA FAERS reports mention Blood pressure increased. 103,788 reports have a serious outcome flag.
Medicines named as suspect
- Infliximab: 6,069 reports
- Valsartan: 5,986 reports
- Rituximab: 4,801 reports
- Amlodipine: 4,479 reports
- Hydrochlorothiazide: 3,786 reports
- Adalimumab: 3,320 reports
- Cabozantinib: 3,183 reports
- Octreotide: 3,070 reports
- Omalizumab: 2,975 reports
- Methotrexate: 2,701 reports
- Tocilizumab: 2,621 reports
- Etanercept: 2,500 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.